A detailed history of Spire Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Spire Wealth Management holds 25,063 shares of ABT stock, worth $2.59 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
25,063
Previous 26,182 4.27%
Holding current value
$2.59 Million
Previous $2.88 Million 1.15%
% of portfolio
0.09%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$109.52 - $120.96 $122,552 - $135,354
-1,119 Reduced 4.27%
25,063 $2.85 Million
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $292,486 - $358,027
-3,243 Reduced 11.02%
26,182 $2.88 Million
Q3 2023

Nov 08, 2023

SELL
$95.53 - $114.62 $260,605 - $312,683
-2,728 Reduced 8.48%
29,425 $2.85 Million
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $237,236 - $264,330
-2,354 Reduced 6.82%
32,153 $3.51 Million
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $2.8 Million - $3.29 Million
-28,883 Reduced 45.56%
34,507 $3.49 Million
Q4 2022

Feb 03, 2023

BUY
$95.06 - $111.52 $226,242 - $265,417
2,380 Added 3.9%
63,390 $6.96 Million
Q3 2022

Nov 07, 2022

SELL
$96.76 - $112.03 $3.9 Million - $4.51 Million
-40,281 Reduced 39.77%
61,010 $5.9 Million
Q2 2022

Jul 22, 2022

SELL
$102.07 - $123.37 $3.31 Million - $4 Million
-32,446 Reduced 24.26%
101,291 $11 Million
Q1 2022

Apr 18, 2022

SELL
$114.02 - $139.04 $1.98 Million - $2.42 Million
-17,380 Reduced 11.5%
133,737 $15.8 Million
Q4 2021

Jan 14, 2022

BUY
$115.53 - $141.46 $1.24 Million - $1.52 Million
10,741 Added 7.65%
151,117 $21.3 Million
Q3 2021

Oct 22, 2021

BUY
$116.66 - $129.06 $782,905 - $866,121
6,711 Added 5.02%
140,376 $16.6 Million
Q2 2021

Jul 26, 2021

SELL
$105.79 - $124.53 $1.18 Million - $1.39 Million
-11,158 Reduced 7.7%
133,665 $15.5 Million
Q1 2021

May 21, 2021

BUY
$108.84 - $128.23 $15.8 Million - $18.6 Million
144,823 New
144,823 $16.7 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.